Canadian government concessions to the big multinational pharmaceutical companies, including an extension of their monopoly on new drugs to 20 years, have resulted in sharply escalating prices for drug prescriptions, the potential blocking of a national Pharmacare program, and Canadian complicity in denying life-saving drugs to developing countries.